Dr. Otavio Berwanger and Dr. C. Michael Gibson Discuss: Rivaroxaban Versus Warfarin In Patients With Bioprosthetic Mitral Valves And Atrial Fibrillation Or Flutter: Primary Results From The RIVER Randomized Trial November 14, 2020 Disclosures: TBA
Dr. Robert Byrne and Dr. C. Michael Gibson Discuss: COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients October 17, 2020 Disclosures: TBD
Dr. Damien Collison and Dr. C. Michael Gibson Discuss: TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization October 16, 2020 Disclosures: TBD
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: Disrupt CAD III: Safety and Effectiveness of Intravascular Lithotripsy for Treatment of Severe Coronary Calcification October 16, 2020 Disclosures: TBD
Dr. Junjie Zhang and Dr. C. Michael Gibson Discuss: ULTIMATE: Three-Year Outcomes After IVUS-Guided vs Angiography Guided DES Implantation October 15, 2020 Disclosures: TBD
Dr. Jeffrey Moses and Dr. C. Michael Gibson Discuss: REFLECT II: A Randomized Trial of a Cerebral Embolic Protection Device During TAVR October 15, 2020 Disclosures: TBD
Dr. Corrado Tamburino and Dr. C. Michael Gibson Discuss: SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses October 14, 2020 Disclosures: TBD
Dr. Philipp Lurz and Dr. C. Michael Gibson Discuss: MITHRAS: A Randomized Trial of ASD Closure After TMVr October 14, 2020 Disclosures: TBD
Dr. Timothy Henry and Dr. C. Michael Gibson Discuss: NACMI: Outcomes From the North American COVID-19 STEMI Registry October 14, 2020 Disclosures: TBD
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: XIENCE 90/28: Assessment of Three-Month and One-Month DAPT After Everolimus-Eluting Stents in High-Bleeding Risk Patients October 14, 2020 Disclosures: TBD